D

Dermavant Sciences, An Organon Company

Biotechnology Research · United States · 500 employees

14 Decision makers
500 Employees
$13M Revenue
2016 Founded

Organizational Chart of Dermavant Sciences, An Organon Company

Roles identified within Dermavant Sciences, An Organon Company's leadership team, from public professional data, updated 25 Oct 2026.

Department

Dermavant Sciences, An Organon Company's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Dermavant Sciences, An Organon Company by function

General management

Sales

Finance

See all Dermavant Sciences, An Organon Company contacts on Zeliq

Decision makers at Dermavant Sciences, An Organon Company

14 identified 2 VP 12 Directors
See them on Zeliq →

Funding and news at Dermavant Sciences, An Organon Company

Funding

Last round Private equity · $160M
Total funding $180M (2 rounds)
Debt Financing $20M May 2019
Private Equity Round $160M Jun 2021

Team Structure headcount by department

Sales
71
General Management
5
Research
4
Medical
3
Operations
3
Consulting
2
Education
2
Marketing
2

How to prospect Dermavant Sciences, An Organon Company's departments

Sales

With 71 people, this is the organisation's biggest team. These profiles handle outreach daily and respond well to concrete pitches about pipeline, productivity and prospecting tooling.

General Management

The company's second-largest department (5 people). General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Research

This department counts 4 people. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Medical

3 people work in this department. Regulatory constraints and protocols shape everything here: show you understand their compliance context before pitching.

Operations

A team of 3 people. Process efficiency and cost control are the angles that resonate with these decision makers.

Consulting

This department counts 2 people. Billable time is the key metric: anything that reduces non-billable work deserves a spot in your opener.

Try the Zeliq email finder demo →

FAQ Dermavant Sciences, An Organon Company

Who runs Dermavant Sciences, An Organon Company?

The highest-ranking leadership role identified at Dermavant Sciences, An Organon Company is “VP of Finance”, based on public data updated 25 Oct 2026.

How many decision makers does Dermavant Sciences, An Organon Company have?

14 decision makers identified.

How do I contact a decision maker at Dermavant Sciences, An Organon Company?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Dermavant Sciences, An Organon Company

More companies to explore

Biotechnology Research · United States

Same group · organon.com

All Biotechnology Research companies in United States →

About Dermavant Sciences, An Organon Company

Dermavant Sciences, An Organon Company is a business specialised in Biotechnology Research, operating from United States. Founded in 2016, the company has a workforce of roughly 500 people. As part of the broader Professional Services sector, Dermavant Sciences, An Organon Company operates specifically in the Biotechnology Research segment. Dermavant Sciences, An Organon Company is a B2B company, primarily serving business clients and professional organisations. Dermavant Sciences, An Organon Company has raised funding across 2 rounds totalling $180M. Annual revenue is estimated at around $13M. Sales teams can rely on this profile to qualify Dermavant Sciences, An Organon Company, spot business signals, and connect with verified decision makers.

Activity & Market

Dermavant Sciences, An Organon Company operates in the Biotechnology Research segment, part of the broader Professional Services sector. As a B2B company, Dermavant Sciences, An Organon Company primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.